(Q28190437)
Statements
Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention results: from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial (English)
0 references
6 September 2005
0 references
46
0 references
5
0 references
761-9
0 references